Identity & classification
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH), based on a modified GRF(1-29) sequence and available in forms with or without a drug-affinity complex (DAC). It is classed among GHRH-analog peptides.
Research context
CJC-1295 is used as a reference GHRH analog in in-vitro and preclinical endocrine research.
Forms & handling
Supplied lyophilized for laboratory research use only. Store at -20 °C protected from light; reconstitute with bacteriostatic water for laboratory use and hold reconstituted material at 2–8 °C.
IDENTITY
TECHNICAL DATA- CLASS
- GHRH analog (with / without DAC)
- PURITY TARGET
- ≥ 99% by HPLC
- PRESENTATION
- 2 MG · LYOPHILIZED
- ALSO KNOWN AS
- Modified GRF (1-29), DAC:GRF
Material supplied by Peptide Wholesalers is for laboratory research use only. It is not a drug, supplement, cosmetic, or article intended for human or veterinary use.
WHOLESALE THIS COMPOUNDCJC-1295 is stocked for wholesale supply — tested by HPLC+MS, COA on file, from 1,000 vials.
View CJC-1295 wholesale →FREQUENTLY ASKED
2 ITEMSWhat is CJC-1295?
CJC-1295 is a ghrh analog (with / without dac) supplied for laboratory research use only. Material supplied by Peptide Wholesalers is for laboratory research use only. It is not a drug, supplement, cosmetic, or article intended for human or veterinary use.
Is CJC-1295 available wholesale?
Yes. CJC-1295 is stocked for wholesale supply to resellers and institutions, tested by HPLC+MS with a certificate of analysis on file. See the CJC-1295 product page for order minimums and to request a quote.